Table 2. Symptom score, endoscopic finding score, histological score, and inflammatory markers in antibiotics and placebo groups.
Variable | Antibiotic group (n = 12) | Placebo group (n = 8) | P-value |
Mean symptom score (range) | |||
at entry | 5.8 (4–13) | 6.3 (2–13) | P>0.2 |
at 3 months | 3.3 (0–8) | 4.1 (1–12) | P>0.2 |
Mean endoscopic finding score (range) | |||
at entry | 2.2 (1–3) | 1.9 (1–3) | P>0.2 |
at 3 months | 1.6 (0–3) | 1.6 (1–3) | P>0.2 |
Mean histological score (range) | |||
at entry | 3.2 (2–4) | 2.9 (2–4) | P>0.2 |
at 3 months | 2.6 (1–3) | 2.6 (2–4) | P>0.2 |
ESR (range) | |||
at entry | 19.2 (1–57) | 11.8 (1–19) | P>0.2 |
at 3 months | 10.6 (1–30) | 10.86 (1–26) | P>0.2 |
CRP (range) | |||
at entry | 0.4 (0.1–1.6) | 0.4 (0.1–1.5) | P>0.2 |
at 3 months | 0.1 (0–0.3) | 0.2 (0.1–0.6) | P = 0.072 |
WBC (range) | |||
at entry | 5850 (3200–9700) | 5863 (3100–11600) | P>0.2 |
at 3 months | 5517 (3100–9000) | 6213 (3700–9200) | P>0.2 |
Symptom grades were scored according to Lichtiger et al.'s symptom score. Endoscopic and histological findings were scored according to Matts's grading score. ESR: erythrocyte sedimentation rate (mm). CRP: C-reactive protein (mg/dl). WBC: white blood cell (count/µl).